Two new organotin (IV) dithiocarbamate compounds, which are diphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate (compound 1) and triphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate (compound 2), were tested for their toxicity against human erythroleukemia cells (K562). The potential of both compounds to induce cytotoxicity against K562 cells was determined via MTT assay for 24 hours. The mode of K562 cells' death induced by both compounds was determined by Annexin V-FITC/PI staining assay for 24 hours using the IC 50 values obtained from the MTT assay for each compound. This study found that compound 1 and compound 2 were very toxic to K562 cells, producing IC 50 values of less than 5.0 μg/cm 3 . Compound 1 showed higher cytotoxicity against K562 cells with an IC 50 value of 4.0 µM (2.41 μg/cm 3 ) compared to compound 2 which has an IC 50 value of 8.0 µM (4.52 μg/cm 3 ). In addition to that, both compounds were found to induce about 43.0% of K562 cell death via apoptosis. In conclusion, the compounds showed good potential to be developed into anti-leukemic agents due to their strong cytotoxicity against K562 cells leading to induction of cell death via apoptosis. Further studies on their mechanisms of action are warranted in order to explore their potential to be developed into anti-leukemic agents.
INTRODUCTION
Chronic myeloid leukemia (CML) is a slowlyprogressing disease where there are too many myeloblasts (white blood cells that do not mature) found in the bone marrow and blood (National Cancer Institute, 2015a) . About 15% of patients with CML are adults, with an estimation of 6,660 new cases diagnosed in United States in 2015 (Siegel et al., 2015) . According to the National Cancer Institute (2015b), CML can occur at any age even though the median age of patients diagnosed with CML is 64 years old.
Most individuals who are diagnosed with CML have a genetic abnormality in their blood cells called the Philadelphia chromosome (Ph) (American Cancer Society, 2016) . According to Rowley (1973) , Philadelphia chromosome is the result of a reciprocal exchange between the long arms of chromosome 9 with chromosome 22. As a result, it causes the formation of gene combination that causes leukemia, which is the BCR-ABL gene. The BCR-ABL gene causes the production of an enzyme called tyrosine kinase that leads to CML. Improved and continuous ABL tyrosine kinase activity in chronic leukemia cells (K562) will inhibit apoptosis (Bedi et al., 1994; McGahon et al., 1994) .
Organotin derivatives were identified to possess the potential to combat cancer (Alama et al., 2009) . Over the past few years, a number of studies were conducted using organotin compounds with various functional groups, such as carboxylic acids, amino acids, heterocyclic, and sulfur-based ligands (Han and Sheng, 2006) . Interestingly, the biological activity of organotin compounds is strongly influenced by their molecular structures and most of them are highly toxic even at very low concentrations (Pellerito et al., 2006) . Most current studies showed that organotin (IV) compounds can induce cell death at low concentrations, and therefore exhibited better cytotoxic potential than certain clinical drugs (Alama et al., 2009; Du et al., 2011; Ruan et al., 2011; Yamaguchi et al., 2007) . A few other previous studies have shown the potential of organotin (IV) to induce cell death via apoptosis. According to Girasolo et al. (2010) , most organotin (IV) compounds, with the exception of dimethyltin (IV) compounds, showed significant cytotoxicity toward HT-29 cells and was suggested to cause cell death via apoptosis.
Understanding the apoptotic mechanism for a disease is very important as it gives an idea about the pathogenesis of an illness and also provides clues on how the disease can be treated (Wong, 2011) . The mode of cell death can occur either through apoptosis or necrosis, of which can be identified using Annexin V-FITC and propidium iodide staining assay. Apoptosis is described by its morphological features which include cell shrinkage, condensation of chromatin, and nucleus fragmentation (Kerr et al., 1972; Wyllie et al., 1980) . Apoptotic cells involve the translocation of phosphatidylserine (PS) out of the plasma membrane, which subsequently results in the exposure to external cellular activity (Alabsi et al., 2012) . It was demonstrated that (Engeland et al., 1998 ) the ability to stain plasma membranes by Annexin V binding containing PS with the presence of calcium ions (Ca 2+ ) indicates cell death via apoptosis. In this study, two new organotin (IV) dithiocarbamate compounds, which are diphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 1) and triphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 2) (Mohamad et al., 2018) were tested for their toxicity against human chronic myeloid leukemia cells (K562). The aim of this study is to determine the cytotoxic effects and the mode of cell death induced by the new organotin (IV) compounds (2-methoxyethyl) methyldithiocarbamate toward K562 cells.
MATERIALS AND METHODS

Compounds
Diphenyltin (IV) (compound 1) and triphenyltin (IV) (compound 2) (2-methoxyethyl) methyldithiocarbamate compounds were synthesized at the School of Chemical Sciences and Food Technology, Faculty of Science and Technology, The National University of Malaysia (UKM) Bangi. An in situ method was used to synthesize the compounds, whereby (2-methoxyethyl)-methylamine was reacted with carbon disulfide (CS 2 ) and ammonia solution in ethanol for 2 hours at <4°C to form the dithiocarbamate ligand. The respective organotin (IV) chloride salts were then dissolved in cold ethanol and slowly added to the ligand mixture and stirred for another 2 hours to form the organotin (IV) dithiocarbamate compounds. The synthesis was conducted as described by Mohamad et al. (2016) . Table 1 shows the important physical analysis of both compounds.
Stock preparation
The stock solutions of compound 1 (10 mM) and compound 2 (10 mM) were prepared by dissolving 0.006 and 0.005 g into 1 ml of dimethylsulfoxide (DMSO). The stock solutions were kept at −20°C and were diluted at a certain concentration prior to the treatment of the cells. Menadione (MENA) was chosen as the positive control in this study as it has been found to induce apoptosis in K562 cells through oxidative stress mechanism (Bonilla-Porras et al., 2011) . Menadione also acts as a verifier for the IC 50 values obtained from the compounds as its cytotoxic concentrations have been previously established on several leukemic cells, including Figure 1. Chemical structure of diphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 1) . Chemical structure of triphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 2) (Mohamad et al., 2018) .
K562 (Bonilla-Porras et al., 2011; Nutter et al., 1991; Verrax et al., 2006; Wang et al., 2017; Wu et al., 1993) . The stock solution of MENA (30 mM) was prepared by dissolving 0.005 g of MENA in 1 ml of DMSO. The stock solution was also kept at −20°C.
Cell culture
K562 human chronic myeloid leukemia cell line was purchased from the American Type Culture Collection (ATCC). The cells were maintained in Iscove's Modified Dulbecco's medium (GIBCO, USA) enriched with 10% fetal bovine serum (Biowest, USA). The cell line was maintained at 37°C in 5% of carbon dioxide (CO 2 ) atmosphere according to the recommended protocols by ATCC.
Cell viability assessment
The K562 cells (5.0 × 10 5 cells/ml) was seeded and treated with compound 1 and compound 2 with the highest concentration of 10.0 µM in 96-well plates. The desired concentrations gradient was obtained via serial dilution method. The cells were exposed to the compounds for approximately 24 hours. Upon 24 hours of incubation, 20 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) salt solution (5 mg/ml) was added into each of well and was incubated for 4 hours. After 4 hours of incubation, an amount of 180 μL supernatant was removed from each well prior the addition of 180 μL DMSO. The cells were incubated for another 15 minutes to allow the formazan crystals to be fully dissolved, followed by optical density (OD) measurement using ELISA microplate reader at 570 nm wavelengths.
Mode of cell death assessment
The K562 cells were seeded in six-well plate (5.0 × 10 5 cell/ml) and treated with both compounds at their respective IC 50 concentrations. The treated cells were incubated for 24 hours. Upon the completion of 24 hour incubation, 200 μL of cells were harvested and transferred into a micro centrifuge tube. The sample was centrifuged at 200 g for 5 minutes at 4°C. Then, the supernatant was discarded and 500 μL of cold PBS was added into the sample prior to the centrifugation for 5 minutes. The supernatant was then discarded. Next, 150 μL of Annexin V binding buffer and 5.0 μL of Annexin V-FITC were added to the sample in a dark condition. The samples were incubated for 15 minutes at the room temperature. Next, an amount of 10 μL propidium iodide was added to the samples followed by 2 minutes of incubation at the room temperature. After the incubation period, an amount of 350 μL of Annexin V binding buffer was added to the samples and transferred into falcon tubes. Finally, the samples were analyzed using BDFACS Canto II flow cytometer.
Statistical analysis
Statistical Analysis Statistical evaluations of the percentage of viable cells along with the concentration of compounds used to treat the cells were calculated using Statistical Package for Social Sciences (SPSS) version 23.0 by employing a one-way analysis of variance. A probability of 0.05 or less was deemed statistically significant (p < 0.05).
RESULTS AND DISCUSSION
This research was conducted to evaluate the cytotoxic effects induced by di-and triphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compounds against human erythroleukemic cell line (K562 cell) using MTT assay. The graphs in Figures 3 and 4 show that both diphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 1) and triphenyltin (IV) (2-methoxyethyl) methyldithiocarbamate compound (compound 2) were able to reduce 50% of the K562 cells' viability at the concentrations 4.0 (2.41 μg/cm 3 ) and 8.0 µM (4.52 μg/cm 3 ), respectively. Table 2 shows the summary of IC 50 values observed from both compounds as well as the positive control, menadione on K562 cells. The IC 50 values (in µM) obtained were converted to μg/cm 3 using the formula for the purpose of cytotoxic classification (How et al., 2008) : Dithiocarbamate derivatives are lipophilic compounds with a higher level of solubility in organic solvents than in water, which is one of the important factors for biological activities (Rutkowska et al., 2013 ). An environment of high lipophilicity helps facilitate the transport of compounds through the membranes in biological systems as well as helping in the complex formation between compounds and the receptor-binding. Therefore, it is suggested that lipophilic properties assist in the process of transporting the compounds across the cell membrane. It was (Huang et al., 2009) who found that the lipophilic nature of this compound has helped in the intracellular interaction, thereby exerting cytotoxicity against the cells.
The MTT assay results showed that compound 1 induced stronger cytotoxicity on the K562 cells as compared to compound 2. This was deduced from the IC 50 value obtained for compound 1 that was 4.0 µM (2.41 μg/cm 3 ), which was lower than compound 2 that was 8.0 µM (4.52 μg/cm 3 ). According to a previous study of How et al. (2008) , compounds with IC 50 values less than 5.0 µg/cm 3 are classified as very toxic compounds. Most researchers found that triphenyltin compounds gave stronger cytotoxic effects on the tested cells compared to diphenyltin compounds. This is because triphenyltin consists of three phenyl groups, while diphenyltin consists of only two phenyl groups attached to the tin (Sn) atom. The size and nature of the lipophilic properties of the phenyl, which is a large lipophilic and aromatic group, had been suggested to affect the cytotoxic effects induced by compound 1 and compound 2 against the K562 cells. In addition, organotin (IV) compounds are also characterized as electron acceptors, thus the toxicity of the compounds is proposed to be due to the interactions between the electron donor groups in biomolecules (Awang et al., 2011) . Interestingly in this study, the diphenyltin (IV) compound showed better potency on K562 cells as compared to the triphenyltin (IV) compound. However, statistical analysis showed no significant difference (p < 0.05) between both compounds in the study. This study was supported by the research conducted by Gielen and Tiekink (2005) in which the di-and triorganotin (IV) compounds induced strong anti-proliferative effects against many types of cancer cells. This effect is due to the coordination of the ligand by atom or groups to the central metal atom. Thus, it can be suggested that the cytotoxicity of diphenyltin and triphenyltin are quite similar against K562 cells. Figure 5 shows the percentage of viable, apoptotic and necrotic K562 cells upon treatment with compounds 1, 2 and menadione at their respective IC 50 concentrations. In the present study, it was found that the percentage of the externalization of PS in K562 cells when treated with IC 50 concentrations for 24 hours for both di-and triphenyltin compounds were about 43.0%. The results in this assay show similarities with the IC 50 values obtained in the MTT assay. Approximately, 50% of viable K562 cells were detected in the Annexin V-FITC and propidium iodide staining assay compared to the results of MTT assay.
The results from this study also found that the percentage of cells that undergo necrosis for triphenyltin (IV) compound (compound 2) was higher (12.10%) as compared to diphenyltin (IV) compound (compound 1) (2.70%). Apoptotic cell death is a target in developing anticancer treatments. This is because interference of the apoptosis processes promotes tumor initiation and development, and also resistance to treatment (Lowe and Lin, 2000) . Kerr et al. (1972) linked apoptosis to the removal of potentially malignant cells, hyperplasia, and tumor development. The reduction of apoptotic activity or its resistance plays an important role in carcinogenesis. The mechanisms that are proposed to be the contributing factors to the inhibition of apoptosis are the disruption of the balance of pro-apoptotic and anti-apoptotic proteins, the inhibition of the caspase function and the impairment of death receptor signals (Wong, 2011) .
The important features of necrosis are unlike apoptosis as it produces pro-inflammatory responses (Ricci and Zong, 2011) . The inflammatory responses may damage normal tissues, producing mitogenic, or pro-survival cytokine. The molecules can activate the signal pathway that promotes the growth of external cells in the damaged area, and thereby promotes the migration and metastasis of the associated tumor cells (Lotze and Tracey, 2005; Zhou et al., 2004) .
Overall, the results of this study showed that compound 1 and compound 2 were able to induce cytotoxic effects on K562 cells in line with the increased treatment concentration used within 24 hours. Both compounds showed strong cytotoxic effects on the K562 cells with IC 50 values less than 5.0 μg/cm 3 . Other than that, the organotin (IV) compounds were also capable of inducing approximately 50% cell death via apoptosis at their respective IC 50 concentrations upon the treatment for 24 hours.
CONCLUSION
In conclusion, this study has proven that diphenyltin (IV) (2-methoxyethyl) methydithiocarbamate (compound 1) and triphenyltin (IV) (2-methoxyethyl) methyldithocarbamate (compound 2) were able to produce cytotoxic effects on K562 cells in a concentration-dependent manner for a treatment period of 24 hours. Interestingly, the assessment on the mode of K562 cells' death showed that both compounds were able to induce cell death via apoptosis upon the treatment with the IC 50 concentration for 24 hours. This study indicates that both compounds possess good potential in being developed into new anti-leukemic agents.
